Raulken co.UK - Science and Technology Results of landmark statin study revealed

In one of the hottest medical findings in the current year, the JUPITER (Justification for the Use of Statins in Primary Prevention: An Intervention Trial Evaluating Rosuvastatin) Trial showed that statins could cut the risk of heart attack,...

Statins have long been prescribed for people diagnosed with high levels of bad cholesterol in order to lower their risk for heart disease. The drugs work by blocking the enzyme HMG-CoA-reductase, which the body needs to make cholesterol.
However, new research shows that statins could prevent heart disease in people having normal or lower cholesterol levels as well. Jupiter, as the study was called, found that people with normal level of cholesterol but high levels of the protein called CRP who took Crestor were 50 percent less likely to suffer a stroke, need angioplasty or bypass surgery. Also, they were 20 percent less likely to die of a heart attack or stroke.
Paul Ridker, MD, director of the Center for Cardiovascular Disease Prevention at Brigham and Women's Hospital and lead author of the study, said that having normal cholesterol levels does not necessarily mean that you don’t need statins.
The measure, if put into practice, could save million of lives, considering the fact that heart disease is the leading cause of death in the United States. Of course, the measure would also increase sales of statins, which are already top-selling drugs in the US, but they could decrease the number of people rushed to the emergency room with heart attacks or strokes. Moreover, besides reducing the risk for heart disease,...
Click here to read the content (Source eFluxMedia)